)
Edge6 Mar 2026
Upvoted: The Story of Reddit
How Reddit built a unique platform around communities and conversation, turning human insight and intent into a distinctive business model.
Recursion Pharmaceuticals
Recursion Pharmaceuticals (RXRX) investor relations material
Recursion Pharmaceuticals TD Cowen 46th Annual Health Care Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.TD Cowen 46th Annual Health Care Conference summary2 Mar, 2026
Platform and business model evolution
Transitioned from a single-point solution to an integrated platform combining phenotypic screening, transcriptomics, proteomics, and real-world evidence for drug discovery.
Added a novel design platform to explore chemical space and solve previously unsolved industry problems, leveraging leadership with AI and operational expertise.
Unified workflow enables better predictive modeling, aiming to lower clinical failure rates and improve trial design.
Partnership inflows surpassed $500 million, supporting platform investment and risk diversification across multiple clinical and preclinical programs.
Emphasis on disciplined, data-driven decision-making under new leadership, focusing on high-return opportunities and operational rigor.
Strategic partnerships and differentiation
Roche and Sanofi are major partners, with $210 million from Roche for neuroscience PhenoMaps and five discovery milestones achieved with Sanofi.
Partnership structures include upfront payments for development costs and early milestones, with profit realized as partners advance candidates.
Proprietary data assets (over 50 PB) enable unique AI model development, addressing the 90% of the genome not covered by existing drugs.
Integration of multiple modeling systems reduces noise and enhances experimental validation.
Collaboration with tech companies like NVIDIA provides advanced compute infrastructure, accelerating data analysis and model deployment.
Pipeline progress and clinical innovation
REC-4818 in FAP showed dramatic, durable reductions in polyp count, with ongoing FDA engagement to define pivotal trial design.
ClinTech platform accelerated patient enrollment by 30%-50% across several trials, optimizing site selection and patient targeting.
CDK7 program pivoted to ovarian cancer based on mechanistic and clinical data, with combination trial data expected in the first half of 2027.
All pipeline programs are subject to strict go/no-go criteria, with rapid termination if benchmarks are not met.
Upcoming data updates expected for FAP (first half 2024), CDK7 (first half 2027), and additional programs in the second half of 2024.
Quantify burn reduction vs capability expansion?
What unique data assets drive pharma partnerships?
What is ClinTech's impact on trial enrollment speed?
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Next Recursion Pharmaceuticals earnings date
Leerink Global Healthcare Conference 20269 Mar, 2026
Recursion Pharmaceuticals
Next Recursion Pharmaceuticals earnings date
Leerink Global Healthcare Conference 20269 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Recursion Pharmaceuticals Inc is a biotechnology company leveraging machine learning and automation to discover and develop new therapeutics. The company focuses on using its technology platform to identify treatments across a range of diseases, including rare and complex conditions. Recursion Pharmaceuticals operates within the healthcare and biotechnology sectors. The company is headquartered in Salt Lake City, Utah, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage